Corporate Compliance

Other Issuances: OIG issues reports on oxaliplatin, E&M, and more

Medicare Insider, May 5, 2009

Want to receive articles like this one in your inbox? Subscribe to Medicare Insider!

OIG issues review of Palmetto GBA's outpatient payments for oxaliplatin drug services in North Carolina

On April 23, the OIG released a report on outpatient payments for oxaliplatin made in 2004 and 2005 by Palmetto GBA, a Medicare fiscal intermediary in North Carolina. The OIG found that, during these years, Palmetto made overpayments for oxaliplatin services totaling $1.9 million. However, the hospitals had identified and refunded $1.8 million.

View the OIG report.

OIG issues review of oxaliplatin billing at San Joaquin General Hospital for calendar years (CY) 2004 and 2005

On April 20, the OIG released a report on oxaliplatin billing at San Joaquin General Hospital for CYs 2004 and 2005. The OIG found that, during these years, San Joaquin billed Medicare for an incorrect number of service units and received overpayments totaling approximately $42,000.

View the OIG report.

OIG issues review of evaluation and management (E&M) services included in eye and ocular adnexa global surgery fees for calendar year 2005

On April 20, the OIG issued a review of E&M services included in eye and ocular adnexa global surgery fees for calendar year 2005. The OIG determined that global surgery fees did not reflect the number of E&M services provided to beneficiaries because CMS had not adjusted or recently adjusted the relative value units for most of the sampled surgeries.

View the OIG report.



Want to receive articles like this one in your inbox? Subscribe to Medicare Insider!

Most Popular